ArticleCurrent cancer drug targets2024

Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.

Juntao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.